Johnson & Johnson Legend Biotech Corp Transaction History
Johnson & Johnson
- $475 Million
- Q1 2024
A detailed history of Johnson & Johnson transactions in Legend Biotech Corp stock. As of the latest transaction made, Johnson & Johnson holds 814,586 shares of LEGN stock, worth $36.1 Million. This represents 9.62% of its overall portfolio holdings.
Number of Shares
814,586
Previous 814,586
-0.0%
Holding current value
$36.1 Million
Previous $54.7 Million
16.49%
% of portfolio
9.62%
Previous 21.17%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
213Shares Held
63.6MCall Options Held
1.09MPut Options Held
525K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$485 Million0.08% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$265 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$238 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$116 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$106 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.41B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...